Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3031% above fair value
$2.81−0.08 (-2.77%)
Close on Nov 13, 2026Market cap $118.37MP/E –Yield –
Apyx Medical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Apyx Medical's pe ratio was 4.1× on Oct 31, 2019, against 8.2× a year earlier. Over the last 4 years it ranged from 2.7× to 375.0×, with a median of 72.7×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Oct 31, 2019 | 4.1× | +0.7 |
| 2018 | Dec 31, 2018 | 3.4× | −4.8 |
| 2016 | Apr 29, 2016 | 8.2× | −6.8 |
| 2015 | Dec 31, 2015 | 15.0× | −285.0 |
| 2013 | Jul 31, 2013 | 300.0× | +25.0 |
| 2012 | Apr 30, 2012 | 275.0× | +173.3 |
| 2011 | Jan 31, 2011 | 101.7× | −7.7 |
| 2010 | Dec 31, 2010 | 109.3× | – |
See a number that looks wrong?